Cargando…
Neuromuscular Diseases Care in the Era of COVID-19
The COVID-19 pandemic has pushed health systems to their limit and forced readjustment of standards of care for different pathologies. Management of neuromuscular diseases becomes a challenge since most of them are chronic, disabling, progressive, and/or require immunosuppressive drugs. There are th...
Autores principales: | Bertran Recasens, Bernat, Rubio, Miguel Angel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732578/ https://www.ncbi.nlm.nih.gov/pubmed/33329336 http://dx.doi.org/10.3389/fneur.2020.588929 |
Ejemplares similares
-
Care for Patients With Neuromuscular Disorders in the COVID-19 Pandemic Era
por: Tseng, Yung-Hao, et al.
Publicado: (2021) -
Editorial: Diagnosis of neuromuscular disorders in the era of personalized genomic medicine
por: Kazamel, Mohamed, et al.
Publicado: (2023) -
Rehabilitation of Neuromuscular Diseases During COVID-19: Pitfalls and Opportunities
por: Liguori, Sara, et al.
Publicado: (2021) -
Interventional Stroke Care in the Era of COVID-19
por: Salahuddin, Hisham, et al.
Publicado: (2020) -
Editorial: Imaging of Neuromuscular Diseases
por: Diaz-Manera, Jordi, et al.
Publicado: (2021)